The company's exit from the U.K. market would spark a major index re-weighting, given AstraZeneca is the most valuable ...

London marked the slowest first half-year for IPO volume since 1997, a grim milestone punctuated by a report that AstraZeneca ...

AstraZeneca CEO discusses leaving London for US and Japan facing new, bigger tariff - Stock markets updates and business news ...

AstraZeneca’s chief executive has discussed quitting Britain in a move that would deal a significant blow to the City of ...

AstraZeneca is reportedly considering moving its listing to the US. Here's why AZN's expected departure is alarming for the ...

Suggestions that AstraZeneca might cross the Atlantic should act as a huge wake-up call.

The boss of Britain’s most valuable company, Astrazeneca, has reportedly voiced his preference to move the firm’s stock ...

It comes amid reports that the drugs maker is considering moving its listing from the UK to the US in what would be a hammer ...

The approval comes amid speculation that the big pharma company may switch its UK stock market listing to the US.

AstraZeneca is considering moving its stock market listing from London, where it is the exchange's most valuable company, to ...

Reports are circulating that AstraZeneca shares could be moving off the London exchange with its CEO favouring a US market ...

Pressure is piling on London's stock exchange, with reports that British pharma giant AstraZeneca may move its listing to the U.S. delivering yet another blow this week. Stream Connecticut News ...